biomarkers
A 2024 PCOS study showed biomarker‑driven control lowers inflammation. We explain the mechanism, link related research, and give a 14‑day self‑experiment to test supplement timing.
biomarkers
A recent biomarker study links DAB2, leptin and gut mimicry to disease pathways. We outline a 10‑day self‑experiment using targeted supplements to test short‑term healthspan markers.
precision-medicine
Recent work suggests biomarker‑guided supplementation could extend healthspan by over a decade. We outline the mechanism, evidence, and a simple 14‑day self‑experiment.
personalization
Evidence from consumer‑behavior studies suggests algorithmic personalization can increase supplement adherence. Try a 10‑day self‑experiment to test the hypothesis yourself.
biomarkers
A 2026 rheumatoid arthritis trial linked biomarker panels to relapse risk, suggesting that timed supplementation could reduce 12‑month recurrence. We explain the mechanism and give a 10‑day self‑study plan.